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Bovine cryptosporidiosis: impact, 
host-parasite interaction and control strategies
Sarah Thomson1 , Carly A. Hamilton2, Jayne C. Hope2, Frank Katzer1, Neil A. Mabbott2, Liam J. Morrison2 
and Elisabeth A. Innes1*
Abstract 
Gastrointestinal disease caused by the apicomplexan parasite Cryptosporidium parvum is one of the most important 
diseases of young ruminant livestock, particularly neonatal calves. Infected animals may suffer from profuse watery 
diarrhoea, dehydration and in severe cases death can occur. At present, effective therapeutic and preventative meas-
ures are not available and a better understanding of the host–pathogen interactions is required. Cryptosporidium par-
vum is also an important zoonotic pathogen causing severe disease in people, with young children being particularly 
vulnerable. Our knowledge of the immune responses induced by Cryptosporidium parasites in clinically relevant hosts 
is very limited. This review discusses the impact of bovine cryptosporidiosis and describes how a thorough under-
standing of the host–pathogen interactions may help to identify novel prevention and control strategies.
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1 Introduction
Cryptosporidium parvum was first described in 1907 by 
Edward Ernst Tyzzer in the small intestine of mice [1]. 
Since then, over 30 species of Cryptosporidium have been 
described that infect a wide range of host species [2]. 
Several species infect cattle and have a significant impact 
upon animal health and production, especially in young 
calves. Unfortunately, relatively few tools are available 
to combat bovine cryptosporidiosis (no vaccine and one 
drug of limited utility), and our knowledge of host–path-
ogen interactions in the bovine host is also very limited. 
Addressing these important gaps in our understanding 
of bovine cryptosporidiosis will aid the development of 
interventions going forward. This review summarises our 
current understanding of bovine cryptosporidiosis, with 
a particular focus on what is currently known about the 
bovine immune response to this pathogen, and discusses 
avenues for new research to further our understanding of 
host-parasite interactions in bovine cryptosporidiosis.
Cryptosporidiosis was first reported in cattle in the 
early 1970s [3], but the observed clinical disease could 
not be solely attributed to Cryptosporidium as there was 
evidence of co-infection with other viral and bacterial 
pathogens. In 1983, neonatal diarrhoea in experimentally 
infected calves was reported with Cryptosporidium spe-
cies as the single infective agent [4]. Cryptosporidiosis 
is now recognised as endemic in cattle worldwide and is 
one of the most important causes of neonatal enteritis 
in calves globally [5–7]. Veterinary surveillance reports 
show cryptosporidiosis has been the main diagnosed 
cause of enteritis in calves in the UK between 2007 and 
2011 (Figure 1) [8].
1.1  Parasite life cycle
Cryptosporidium oocysts are transmitted between hosts 
via the faecal-oral route, either directly via contact with 
faeces from infected hosts, or indirectly through envi-
ronmental contamination or ingestion of contaminated 
food or water. Following ingestion of infective Crypto-
sporidium oocysts by the host, the conditions in the gas-
trointestinal tract (low pH and body temperature) trigger 
oocyst excystation and four sporozoites are released (Fig-
ure 2A). Cryptosporidium parvum sporozoites adhere to 
epithelial cells (Figure 2B) of the ileum, specifically at the 
Figure 1 Pathogens causing diarrhoea in young calves. Cryptosporidium is the most commonly detected pathogen causing diarrhoea in 
calves less than 1 month of age as a proportion of diagnosable submissions 2007–2011 (veterinary investigation diagnosis analysis [VIDA]).
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ileocaecal junction in the case of C. parvum. Following 
attachment, the sporozoites become incorporated within 
a parasitophorous vacuole formed by the host cell mem-
brane yet remain extracytoplasmic. A feeder organelle, 
unique to Cryptosporidium and present in all intracel-
lular stages, acts as the interface between the parasite 
and the host cell. The feeder organelle enables the para-
site to obtain all necessary nutrients from the host while 
still being protected from the host immune response and 
hostile gut conditions (Figure 3). 
After the development of the feeder organelle the 
sporozoite itself becomes more spherical in shape and 
forms a trophozoite (Figure  2C). The parasite begins 
asexual reproduction (Figure  2D) and develops into a 
type I meront (Figure 2E) which releases merozoites. The 
merozoites that are formed within the type I meront can 
immediately re-infect the host, by invading neighbouring 
epithelial cells and beginning asexual reproduction again, 
or develop into a type II meront.
Type II meronts release four merozoites that initiate 
the sexual reproductive cycle. The released merozoites 
invade host cells and differentiate into either macroga-
monts (Figure 2H) or microgamonts (Figure 2G). Micro-
gamonts develop multiple nuclei and release free 
microgametes that penetrate and fertilise the macro-
gamete, producing a zygote (Figure  2I). Meiosis occurs 
and the zygote differentiates into four sporozoites as the 
oocyst develops and is released from the lumen.
The sporozoites may be released directly into the 
lumen either from thin-walled oocysts (Figure  2K) 
that re-infect the host, or are contained in thick-walled 
oocysts (Figure  2J) which are shed in faeces and are 
immediately infective for other hosts [10]. The ability to 
produce thin-walled oocysts which enable auto-infec-
tion of the host is one of the reasons why the Crypto-
sporidium parasite is so successful. This auto-infection 
means that the parasite can produce many new oocysts 
in a relatively short time.
Figure 2 Life cycle of Cryptosporidium. Ingested sporulated oocysts release four sporozoites that invade host epithelial cells and develop into 
trophozoites, before undergoing asexual and sexual reproduction, resulting in the generation of both thin and think walled oocysts. Thin-walled 
oocysts auto-infect epithelial cells and thick-walled oocysts are excreted in the faeces of the host. Reproduced from [9].
Page 4 of 16Thomson et al. Vet Res  (2017) 48:42 
Thick-walled sporulated oocysts are excreted by 
infected hosts and are very resistant to many environ-
mental conditions [11, 12]. Oocysts survive for several 
months in cool, moist climates, but can be inactivated 
by desiccation [13]. Environmental contamination and 
oocyst persistence is a significant factor in the epidemiol-
ogy of bovine cryptosporidiosis.
2  Bovine cryptosporidiosis
Four species of Cryptosporidium are commonly found in 
cattle: C. parvum, C. bovis, C. ryanae and C. andersoni, 
but only C. parvum is associated with clinical disease in 
neonatal calves [14, 15], with older animals (> 6 weeks) 
exhibiting asymptomatic shedding of oocysts.
There tends to be an age-related distribution [16] of 
these species with C. parvum, C. bovis and C. ryanae 
infecting the small intestine of weaned calves. Crypto-
sporidium bovis and C. ryanae have not yet been asso-
ciated with clinical disease in any age group of cattle 
although one study from Sweden reported the presence 
of C. bovis as a single pathogen in diarrhoeal samples 
(n = 6) from calves aged > 21 days, this suggests that C. 
bovis may have pathogenic potential [17]. Cryptosporid-
ium andersoni is more frequently found in adult cattle 
then younger animals and infects the abomasum [18]. 
The clinical signs associated with C. andersoni include 
a reduction in weight-gain and milk yield in adult cows 
[19].
One suggestion for the age-related distribution of 
Cryptosporidium species seen in several host species is 
that changes in the gut microflora as the animal matures 
or due to dietary changes may affect the ability of the par-
asite to infect the gut. While there are no experimental 
trials demonstrating this in cattle, Kvac et al. [21] inves-
tigated the age-related susceptibility of pigs to C. scro-
farum; previous work had indicated that while C. suis 
infected all age groups of pigs it appeared that C. scro-
farum only infected older animals [20]. In their study, 
groups of 4, 5, 6, 7 and 8  weeks-old naïve piglets were 
infected with C. scrofarum oocysts and faecal samples 
were collected and examined for the presence of oocysts. 
The study found that oocysts were only detected in the 
faeces of animals > 5 weeks of age. Additionally, no para-
site DNA was detected in the gut samples of the 4 week 
old pigs at post-mortem while C. scrofarum DNA was 
detected in the duodenum, ileum and jejunum of the 
older pigs. The authors suggested that changes to the gut 
at weaning, while the piglets were adapting to a new diet 
may make the gut easier for the parasite to invade [21].
Neonatal animals infected with C. parvum may suffer 
from profuse watery diarrhoea, inappetence, lethargy, 
dehydration and in some cases death can occur. The 
onset of diarrhoea usually occurs around 3–4 days after 
ingestion of infective oocysts and lasts for approximately 
1–2  weeks. Oocyst shedding occurs between 4 and 
12  days post-infection though this can vary depending 
on the initial challenge dose [22] and oocyst shedding is 
not always associated with diarrhoea. Infected calves can 
shed large numbers (over 1 × 1010) of oocysts each day 
[23], which are immediately infective to other suscepti-
ble hosts [23]. Very few C. parvum oocysts are required 
to cause infection in susceptible hosts, although evidence 
suggests this varies according to parasite isolate. As few 
as nine oocysts of the TAMU isolate caused disease when 
tested on human volunteers, whereas in the same study 
the infective dose was 87 and 1042 oocysts for the IOWA 
Figure 3 Parasite invasion in host cells. Images illustrate a Cryptosporidium sporozoite invading host epithelial cells (left) and a Cryptosporidium 
trophozoite within the parasitophorous vacuole (right). Images by kind permission of Saul Tzipori.
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and UCP isolates, respectively [24]. A similar study in 
neonatal calves (<  24  h old), experimentally infected 
with C. parvum, demonstrated that as few as 17 oocysts 
were sufficient to cause diarrhoea and oocyst shedding 
[25]. Since naturally infected calves can shed in excess of 
3 × 1010 oocysts over a 6 day period [23], the ability of C. 
parvum to rapidly multiply in the gut and establish infec-
tion after exposure to a small number of oocysts makes 
cryptosporidiosis a difficult disease to control on farms.
2.1  Prevalence
Bovine cryptosporidiosis is widespread and has been 
reported as a major cause of calf enteritis [5–7] in many 
countries throughout the world [26–29]. The prevalence 
of C. parvum infection varies between countries and 
studies. For example, reported C. parvum prevalence 
rates of C. parvum in pre-weaned calves in the UK range 
from 28.0 to 80.0% [28, 30, 31]. Studies from other parts 
of the world have reported prevalence of C. parvum in 
pre-weaned calves from 3.4 to 96.6% [16, 32–38]. A lon-
gitudinal study carried out on a single farm in the USA 
which followed a group of calves (n  =  30) from birth 
to 24  months showed that 96.6% (29/30) of calves were 
positive for Cryptosporidium at 2 weeks of age [35]. This 
demonstrates the high likelihood that almost all calves on 
a farm become infected with Cryptosporidium in the first 
few weeks of life.
The variability in the reported prevalence of C. parvum 
most likely reflects differences in the design of the studies 
and the detection methods used. Animal age at the time 
of sampling is very important as calves aged <  6  weeks 
are most likely to be shedding C. parvum while older 
animals may shed another (non-pathogenic) Crypto-
sporidium species [14, 15]. The type of sample examined 
(diarrhoeic samples versus non-diarrhoeic), nature of the 
study (point-prevalence studies may underestimate prev-
alence) and the techniques employed to examine samples 
can have a significant impact on results. For example, 
one of the most common methods for veterinary diag-
nosis of cryptosporidiosis is microscopy. Though this 
one of the most cost-effective methods for detection of 
the parasite many microscopy methods require a degree 
of technical expertise and do not enable speciation of the 
parasite. Molecular tools are usually used in a research 
setting as these are much more sensitive and provide far 
more information about the parasite such as species and 
genotype [2]. Species can be differentiated using mul-
tiplex polymerase chain reaction (PCR) [39], restriction 
enzymes to digest PCR products into fragments of dif-
ferent sizes [PCR-restriction fragment length polymor-
phism (RFLP)] or by direct sequence analysis. Real-time 
PCR is can also be usedfor Cryptosporidium detec-
tion and can detect as few as 2 oocysts per PCR [40]. 
An advantage of real-time PCR is the ability to quantify 
parasite burden as standard PCR can only indicate the 
presence of parasite DNA but cannot quantify. During 
sample processing, a concentration step prior to micros-
copy or PCR can increase the likelihood of detecting the 
parasite [41, 42], particularly in large samples contain-
ing low oocyst numbers. It is important that the appro-
priate tools are utilised when investigating prevalence of 
Cryptosporidium as using less sensitive methods can lead 
to an underestimation.
2.2  Economic and production impact
The precise economic losses associated with bovine 
cryptosporidiosis have not thus far been examined in 
detail but include the cost of treatment and management 
of enteritis, reduced feed conversion and production effi-
ciency and losses due to animal death. Research by the 
Scottish Agricultural College, which examined 212 calf 
diarrhoea (not necessarily only Cryptosporidium) out-
breaks investigated by 20 veterinary practices, estimated 
that the typical cost associated with management of dis-
ease was a minimum of £34 per calf affected, excluding 
labour [43]. Considering that in some cases it is possible 
that almost all calves within a herd may suffer from diar-
rhoea this cost is not insignificant.
At present, studies looking at the long term effects of 
C. parvum infection in calves have not been carried out. 
However, Cryptosporidium infection can impair growth 
rates in humans, lambs and mice [44–47]. A cohort 
study of children from a slum community in Southern 
India which were infected with C. hominis, C. parvum 
or C. meleagridis showed that children that had suf-
fered from multiple bouts of cryptosporidiosis in the 
first 2 years of life were significantly lighter and shorter 
than children who had only a single episode at 2 years of 
age. However, by 3 years of age there were no significant 
differences in height and weight between children who 
had suffered from single or multiple episodes of crypto-
sporidiosis [44]. An earlier study carried out on children 
aged < 3 months in Peru also found that children infected 
with C. parvum were shorter and lighter than uninfected 
children. By 12 months after the onset of infection, chil-
dren who had been infected were 1.05  cm shorter than 
their non-infected counterparts [45].
Very few studies have been carried out in livestock to 
determine the long term effects of cryptosporidiosis on 
growth. One study in Australia showed that lambs which 
were positive for Cryptosporidium were up to 1.65  kg 
lighter than uninfected lambs at slaughter [46]. A sub-
sequent study involving  >  1000 lambs from eight farms 
in Australia reported that shedding of C. parvum pre-
slaughter was associated with a lower carcass weight 
of up to 2.6  kg compared to lambs which did not shed 
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C. parvum [48]. If a similar reduction in the long term 
growth of calves affected by Cryptosporidium also occurs, 
this may prove costly for farmers due to loss of income 
from lower carcass weights, treatment cost or additional 
feed costs required to get calves to market weight.
2.3  Zoonotic implications
Most human cases of cryptosporidiosis are caused by 
either the zoonotic species C. parvum or the human 
adapted species C. hominis [40]. Together these two spe-
cies account for  >  90% of human infections worldwide 
[49] and 96% of clinical cases in the UK [50].
Cryptosporidiosis in humans can be found worldwide 
in many environments, particularly in developing coun-
tries with poor sanitary conditions [51, 52]. Children 
(<  4  years of age) and the elderly are more susceptible 
to disease than young adults [53] with children tending 
to acquire the infection shortly after, or during weaning 
[54]. Although infection of immunocompetent people 
with Cryptosporidium tends to cause self-limiting diar-
rhoea, cryptosporidiosis is the second biggest cause (after 
rotavirus) of infant diarrhoea and death in Africa and 
Asia [55, 56]. In 2010, it was demonstrated that diarrhoea 
accounted for 10.5% of the 7.6 million deaths of children 
under the age of 5 [57]. Therefore, diarrhoea caused by 
Cryptosporidium can result in a significant number of 
deaths in developing countries.
In the UK, zoonotic transmission of C. parvum peaks 
in the spring months [58] and is thought to be related to 
springtime calving and lambing, and an increase in peo-
ple participating in outdoor activities at this time of year. 
Cases of cryptosporidiosis decreased in the spring of 
2001 during the foot and mouth disease outbreak, most 
likely due to a reduction in the number of young farm 
animals and restrictions on farm animal movement [59, 
60]. Zoonotic transmissions to veterinary students work-
ing in practice for the first time are also common [61–
64], in addition to outbreaks associated with petting zoos 
or farm visits [65, 66].
2.4  Environmental impacts
The rapid amplification of C. parvum within infected 
hosts results in the production of significant numbers of 
oocysts. In addition, the inherent properties of oocysts 
that cause them to persist in the environment, means that 
oocysts represent a significant environmental threat to 
human health. Since one of the most common methods 
of transmission of Cryptosporidium is via contaminated 
water, maintaining water supplies Cryptosporidium-free 
is a major challenge for relevant government agencies and 
water companies. In the UK, livestock pasture often sur-
rounds catchment areas collecting water ultimately des-
tined for drinking water. Outbreaks of cryptosporidiosis 
in humans have often been attributed to contamination 
of water catchments by cattle manure. The hardy nature 
of Cryptosporidium oocysts and their small size makes 
it difficult to eliminate them from drinking water, and 
contamination to a water supply can potentially lead to 
large numbers of people becoming infected. Each year, 
400–900 laboratory-confirmed cases of cryptosporidi-
osis are reported to Health Protection Scotland (HPS) 
and 3000–6000 cases in England and Wales are reported 
to the Health Protection Agency (HPA) [67]. In England 
and Wales between 2000 and 2003 there were six drink-
ing water associated outbreaks of cryptosporidiosis, two 
of which were associated with C. hominis affecting 18 
and 28 people, one with both C. hominis and C. parvum 
affecting 133 people. The remaining three outbreaks were 
all associated with C. parvum and affected 47, 3 and 4 
people respectively [58].
A recent study which analysed the species and geno-
types of Cryptosporidium present within livestock and 
wildlife grazing on a water catchment area with a history 
of cryptosporidiosis revealed that farm livestock (cat-
tle and sheep) and wildlife (red and roe deer) all shed 
the same species of Cryptosporidium (C. parvum) which 
was detected in the local water supply [30]. Genotyping 
results showed that livestock and wildlife also shared 
the same genotype of C. parvum illustrating that trans-
mission of the parasite can occur between livestock and 
wildlife where grazing is shared.
Having a broad range of hosts that can shed millions of 
oocysts, combined with that fact that a low dose of hardy 
oocysts can result in disease in naïve hosts make this par-
asite very widespread and difficult to manage.
3  Current control measures for bovine 
cryptosporidiosis
Cryptosporidiosis is a difficult disease to control (due to 
environmentally stable oocysts, low infective dose and 
high levels of excreted sporulated oocysts) and infection 
may be transmitted to a group of susceptible hosts very 
quickly. The oocysts are resistant to many disinfectants 
[49, 68], there are no vaccines available to prevent the 
disease and available treatment options are limited and 
often rely on rehydration therapy [69].
3.1  Farm management practices
As the oocysts of C. parvum are very difficult to elimi-
nate from the environment an alternative control meas-
ure is to try and reduce the environmental contamination 
in the first place. Frequent removal of faeces and con-
taminated bedding from calving areas and calf houses, 
combined with steam-cleaning and disinfection with a 
suitable disinfectant such as Hydrogen Peroxide based 
disinfectants can help to reduce environmental build up. 
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Thorough cleaning with very hot water followed by dry-
ing [70] can also be effective as the oocysts are suscepti-
ble to extremes of temperature (down to −20 °C and up 
to 60 °C) and desiccation [13].
3.2  Therapeutics
At present, few products are licensed in the UK for the 
treatment or prevention of cryptosporidiosis in livestock 
or humans. Those which are available are not very effec-
tive, and in most cases will only reduce the duration of 
shedding and have little or no effect in immunocompro-
mised patients.
3.2.1  Livestock
The only licensed treatment for cryptosporidiosis in 
calves is halofuginone lactate, the mechanism of action of 
this drug is unknown but it is thought to affect the mero-
zoite and sporozoite stage of the parasite [71]. This drug 
is approved for use in both prevention and treatment of 
cryptosporidiosis in calves but cannot be used in animals 
have shown signs of diarrhoea for > 24 h. As a prophy-
lactic measure the drug should be given within 48  h of 
birth and as a therapeutic agent, within 24 h of the onset 
of symptoms. Halofuginone lactate must be given for 7 
consecutive days, which can be difficult to manage, par-
ticularly for beef calves that are kept with their dams. 
Treatment with halofuginone lactate does not completely 
prevent or cure disease but can reduce oocyst shedding 
and the duration of diarrhoea [72–74]. There are no 
licensed treatments for cryptosporidiosis in sheep, goats 
or pigs.
Several other chemotherapeutic agents have been 
tested for the treatment of cryptosporidiosis in livestock 
but none have resulted in a significant reduction in clini-
cal symptoms. For example, some antibiotics, such as 
paromomycin have shown efficacy against Cryptosporid-
ium oocyst shedding, clinical disease and mortality in 
calves, lambs and goat kids, but these compounds are not 
registered for use in calves [75, 76]. Fayer and Ellis [75] 
showed that experimentally infected calves treated with 
100  mg/kg paromomycin twice daily for 11  days shed 
significantly less oocysts than control (untreated) calves. 
Treated calves also showed a significant reduction in 
duration and severity of diarrhoea. A field trial to test the 
efficacy of paromomycin in naturally infected dairy calves 
showed similar results; ten dairy calves on a farm known 
to have a problem with cryptosporidiosis were treated 
with 100 mg/kg paromomycin once per day for 10 days 
while another group were left untreated. Treated calves 
showed no diarrhoea until after treatment was stopped 
while untreated calves began to develop diarrhoea after 
7 days. The authors suggested that the treated calves only 
showed diarrhoea after treatment was stopped due to 
the continuous parasite challenge in a field environment. 
Oocysts were detected in faecal samples from all calves 
but the shedding of oocysts in treated calves was signifi-
cantly later than in untreated calves [77].
A few coccidiostats, such as decoquinate have been 
tested against Cryptosporidium in neonatal calves with 
limited or no reduction in oocyst shedding [78]. Nita-
zoxanide which is the only licensed treatment for human 
cryptosporidiosis has also been tested on experimen-
tally infected calves and was shown to reduce duration 
of oocyst shedding and severity of diarrhoea in treated 
calves [79] but at present it is not licensed for use in 
cattle.
More recent studies which have evaluated novel 
bumped kinase inhibitors (BKIs) as a potential treatment 
for bovine cryptosporidiosis showed that experimen-
tally infected calves treated with BKIs had a reduction 
in oocyst shedding when compared with untreated con-
trols. One study did not show any differences in diar-
rhoea between the groups but the authors noted that the 
clinical disease seen in the control animals was very mild 
[80]. In another study it was demonstrated that all three 
of the BKIs that were tested alleviated clinical symptoms 
of cryptosporidiosis (when calves were dosed twice daily 
for 5 days) but did not eliminate them completely [81].
3.2.2  Vaccines
Currently, there are no vaccines available to prevent 
cryptosporidiosis in either farm livestock or humans. 
However, several attempts to develop such a vaccine 
have been made, some of which were partially successful 
under experimental conditions. Calves that were immu-
nised with killed (γ-irradiated or lyophilised) C. parvum 
oocysts showed reduced oocyst shedding and diarrhoea 
when compared to non-immunised calves [82, 83]. How-
ever, this vaccine was not effective when tested under 
field conditions [84].
Infection with Cryptosporidium often occurs within 
the first week of life, so attempting to immunise the neo-
natal calves themselves is unlikely to be effective as this 
will not provide sufficient time to induce a significant 
immune response prior to infection [85]. To resolve this 
issue, attempts have been made to immunise pregnant 
cows to produce antibodies against Cryptosporidium 
which can be passed via colostrum to their calves. Calves 
receiving colostrum from cows vaccinated in this man-
ner with recombinant C. parvum were protected against 
diarrhoea and also had reduced oocyst shedding, when 
compared to those calves that received colostrum from 
non-vaccinated cows [86]. However, a commercial vac-
cine has not so far become available as the efficacy of 
recombinant C. parvum has yet to be demonstrated in 
the field.
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Despite several compounds being tested for efficacy 
against cryptosporidiosis in calves, to date, no new drugs 
have reached the market since 1999 when halofuginone 
lactate was approved for use. It is necessary to carry out 
further research to better understand this parasite so that 
new treatment options can be developed.
4  Immunology of cryptosporidiosis
The development of future control methods against 
Cryptosporidium is likely to focus on vaccines and other 
immunotherapies. Therefore, there is an increased need 
to define the immunological parameters associated 
with disease progression. To date, most of the literature 
describing the immune response induced by Crypto-
sporidium parasites has been generated from studies in 
mice. Overall, the immune response to Cryptosporidium 
infection in humans and cattle is poorly understood. 
Studies in these clinically relevant hosts are urgently 
required in order to more effectively identify strategies to 
improve control of cryptosporidiosis. Here, we summa-
rise our current understanding of the immune response 
to C. parvum infection (summarised in Figure 4).
4.1  Innate immune response
4.1.1  Epithelial cells
Intestinal epithelial cells represent the primary cellular 
target for Cryptosporidium infection in  vivo. Pathogen 
recognition receptors (PRRs) are involved in the detec-
tion of molecular features of pathogens by the innate 
immune system (reviewed in [87]). Among the differ-
ent families of PRRs, the toll-like receptors (TLRs) have 
been shown to be important during C. parvum infec-
tion of intestinal epithelial cells. In cattle, mRNA levels 
of TLR2 and TLR4 were increased following infection of 
bovine intestinal epithelial cells with C. parvum, whereas 
the expression of TLR1, TLR3 and TLR5-TLR10 were 
unchanged. Interactions between C. parvum and TLR2/
TLR4 expressed by bovine intestinal epithelial cells 
result in the activation of NFκB and subsequently, pro-
duction of TNFα and IL-8 [88]. Similarly, infection of 
human biliary epithelial cells (cholangiocytes) with C. 
parvum induced recruitment of TLR2 and TLR4 to the 
attachment site of infected epithelial cells [89] and infec-
tion of the human epithelial cell line HCT-8 with C. 
parvum has also been shown to induce the expression 
Figure 4 Model of the immune response to C. parvum. C. parvum oocysts are ingested by the host where they target the ileum of the small 
intestine and undergo excystation. Excysted sporozoites invade epithelial cells of the ileum where they complete asexual and sexual replication 
cycles. Infected epithelial cells produce pro-inflammatory cytokines, chemokines and anti-microbial peptides, which together orchestrate the 
immune response and recruit immune cell populations such as NK cells and γδ T cells to the site of infection. APCs such as DCs and macrophages 
sample antigen at the site of infection and following uptake, migrate to the draining mesenteric lymph nodes where they present antigen to 
CD4+ T cells. Antigen presentation together with the presence of IL-12 and IFNγ from APCs and NK cells/γδ T cells respectively, result in the genera-
tion of a Th1 CD4+ T cell response that is thought to be important during the immune response to C. parvum in humans, cattle and mice.
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of the pro-inflammatory cytokine IL-18 [90]. In addi-
tion to production of pro-inflammatory cytokines and 
chemokines, bovine and human intestinal epithelial cells 
secrete antimicrobial peptides after invasion by Crypto-
sporidium. For example, mRNA levels of β-defensin were 
increased in the intestine of C. parvum-infected calves 
compared with control tissues [91]. The human epithelial 
cell lines HCT-8 and HT-29 secrete increased levels of 
LL-37 and α-defensin-2 respectively after IL-18 stimula-
tion, which could be a mechanism adopted by the host 
to limit Cryptosporidium [90]. As mentioned previously, 
C. parvum infection of human cholangiocytes attracted 
TLR2 and TLR4 to the cell surface, and inhibition of this 
TLR signalling resulted in their reduced expression of 
β-defensin 2 [89]. Taken together, these data suggest that 
TLR signalling through bovine and human epithelial cells 
during C. parvum infection results in the production of 
pro-inflammatory cytokines, chemokines and antimi-
crobial peptides. Whether these responses are impor-
tant to induce a protective immune response to infection 
remains to be determined.
4.1.2  Natural killer (NK) cells
Natural killer cells (NK) are large granular lymphocytes, 
which were identified in the 1970s by their ability to lyse 
malignant or transformed cells without prior sensitisa-
tion [92]. This heterogeneous cell population has diverse 
roles in the immune system and NK cells are the first 
line of defence in the control of viruses, as well as cer-
tain intracellular bacteria and parasites [93–96]. Upon 
activation by the cytokines TNFα, IFNα/IFNβ, IL-12, 
IL-15 or IL-18 produced by accessory cell populations 
such as antigen presenting cells (APC), NK cells have two 
main effector functions. Firstly, NK cells are a significant 
source of immunoregulatory cytokines, primarily IFNγ 
but also TNFα, GM-CSF [97–99], IL-10 [98, 99] and 
IL-22 [100, 101]. Secondly, NK cells display cytotoxicity 
to target cells through the release of preformed, cytotoxic 
granules containing perforin and granulysin [102]. NK 
cells comprise 10–15% of peripheral blood lymphocytes 
in humans [102]. Within bovine peripheral blood, NK 
cells represent 0.5–10% of the total lymphocyte popula-
tion with an increased prevalence in neonatal calves, par-
ticularly those aged between 8–120 days old. In parallel 
with humans and mice, the frequencies of circulating NK 
cells in bovine blood decline with age [103–105].
Natural killer cells exist as distinct subsets across spe-
cies, for example, human NK cells are broadly subdi-
vided based on their differential expression of the cell 
surface markers CD56 and CD16 (FcγRIII) [106, 107]. 
CD56 is not expressed in mice, therefore murine NK cells 
are distinguished by the expression of NK1.1 or CD49b 
[108] and can be further subdivided based on CD27 and 
CD11b expression [109]. NKp46 (NCR1; CD335), a nat-
ural cytotoxicity receptor expressed exclusively by NK 
cells, has been used to identify bovine, ovine and porcine 
NK cells and is recognised as a pan-species marker of NK 
cells [110–113].
The role of NK cells during C. parvum infection has 
been studied in ovine, murine and human models of 
cryptosporidiosis. Within the first few days following 
infection of 1 day old lambs with C. parvum, the abun-
dance of NKp46+ NK cells expressing CD16, CD25 and 
perforin was increased in the gut [114]. In mice, it was 
demonstrated that oocyst shedding was higher in C. par-
vum-infected Rag  2−/− γc−/− mice (mice lacking B, T and 
NK cells) compared with C. parvum-infected  Rag2−/− 
mice (mice lacking B and T cells). Rag  2−/− γc−/− mice 
developed morbidity and died after C. parvum infection, 
but  Rag2−/− mice remained healthy, thus highlighting 
a role for NK cells in reducing disease severity during 
murine C. parvum infection [115]. Although NK cells 
are an important source of IFNγ,  Rag2−/− γc−/− mice were 
able to produce IFNγ despite their lack of NK cells, sug-
gesting an alternative source of this cytokine during C. 
parvum infection [115].
Natural killer cells may also play a role in the clearance 
of C. parvum as human CD3− CD16+ CD56+ NK cells 
activated by IL-15 were able to lyse C. parvum-infected 
epithelial cells in vitro. Lysis of epithelial cells was medi-
ated by engagement of the NKG2D receptor expressed by 
NK cells, with ligands major histocompatibility complex 
(MHC) class I chain-related protein A (MICA) and B 
(MICB) on epithelial cells [116]. Therefore, NK cells may 
play a role in the early protective immune response to C. 
parvum infection in sheep, mice and humans, but their 
role in bovine cryptosporidiosis remains to be elucidated.
4.1.3  γδ T cells
γδ T cells, which have a unique T cell receptor (TCR) 
consisting of one γ chain and one δ chain, constitute a 
minor fraction (5–10%) of the circulating lymphocyte 
population in humans and mice, but are more abundant 
in the gut mucosa. However, γδ T cells are a major sub-
set of lymphocytes in ruminants and constitute up to 
60% of circulating T cells in calves less than 6  months 
of age [117]. γδ T cells are involved in antigen presenta-
tion, cytokine production and regulation of the immune 
response.
Following C. parvum infection of calves, there was a 
significant increase in the frequency of γδ T cells in the 
ileum at day 3 post infection [118]. In a study comparing 
C. parvum infected-TCRα or TCRδ deficient mice, which 
lack αβ T cells and γδ T cells respectively, it was demon-
strated that TCRα deficient mice were unable to clear the 
parasite whereas TCRδ deficient mice were able to clear 
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C. parvum, albeit at a slower rate than wild type (control) 
mice. The authors concluded that γδ T cells are involved 
in the initial control of C. parvum infection in mice and 
αβ T cells are necessary for complete clearance of the 
parasite [119]. Thus, evidence suggests that γδ T cells 
may be involved in the early protective immune response 
to C. parvum in cattle and mice.
4.1.4  Dendritic cells (DCs)
Dendritic cells (DCs) are a heterogeneous population 
of potent APC that are essential mediators of immunity 
[120] and tolerance [121]. Stem cell precursors in the 
bone marrow give rise to circulating myeloid or lymphoid 
precursors that enter tissues and reside as immature 
DCs. Monocytes, macrophages and DCs share a com-
mon progenitor [122]. The cytokine Flt3L drives differen-
tiation of these progenitor cells into DCs [123] and loss of 
Flt3L [124], Flt3 [125] or downstream signalling molecule 
STAT3 [126] reduces the number of DCs in vivo.
Dendritic cells are predominantly found underly-
ing body surfaces including the skin, intestine and the 
trachea. They act as sentinels and respond to infection, 
inflammatory signals or tissue damage by migrating away 
from the periphery towards draining lymph nodes where 
they present antigen and initiate primary T cell mediated 
immune responses [127]. Two weeks after oral expo-
sure of mice to C. parvum, live parasites were detected 
in the mesenteric lymph nodes and were associated with 
CD11c  +  DCs therefore suggesting DCs could take up 
C. parvum in vivo and migrate to the local lymph nodes 
[128]. During migration, DCs undergo maturation that is 
characterised by reduced endocytosis and an augmented 
expression of MHC molecules, costimulatory molecules 
and adhesion molecules. Following in  vitro infection of 
mouse bone marrow-derived dendritic cells (BMDCs) 
with C. parvum sporozoites, DCs increased their expres-
sion of CD40, CD80 and CD86. In addition to augmented 
expression of these co-stimulatory molecules, BMDCs 
exposed to C. parvum produced pro-inflammatory 
cytokines including TNFα, IL-6 and IL-12 [128]. Produc-
tion of IL-12 by C. parvum-infected BMDCs from C3H/
HeJ mice (which lack a functional TLR4 pathway) was 
defective, suggesting that TLR4 signalling is important 
for production of IL-12 by C. parvum-infected BMDCs 
[128].
Interestingly, neonatal mice have a reduced number 
of intestinal CD103+ DCs due to a weak production of 
chemokines (CCL3, CCL4, CCL5, CCL22, CXCL9 and 
CXCL10) by intestinal epithelial cells, which results in an 
increased susceptibility to C. parvum infection. Injecting 
neonatal mice with Flt3L in vivo increased the number of 
CD103+ DCs and coincided with their improved resist-
ance to infection [129]. Conversely, CD11c-DTR-Tg mice 
(depleted of CD11c+ DCs) have an increased susceptibil-
ity to infection with C. parvum. Adoptive transfer of DCs 
stimulated with live sporozoites reduced the parasite load 
therefore illustrating the importance of DCs as mediators 
of C. parvum infection in mice [130].
4.1.5  Macrophages
Macrophages are a diverse population of specialized 
phagocytic cells that are essential for host defense, home-
ostasis and wound repair. They are derived from bone 
marrow precursors and circulating blood monocytes, 
which differentiate into resident macrophages or DCs 
upon tissue entry [131]. Similar to DCs, the functions of 
macrophages include phagocytosis (they are known as 
the ‘professional phagocytes’), antigen presentation and 
cytokine production.
Rag2−/− γc−/− mice are able to produce IFNγ despite 
their lack of NK cells, which suggested an alternative 
source of innate IFNγ during C. parvum infection [115]. 
Further extension of this work demonstrated that deple-
tion of macrophages, by treatment with clodronate-
containing liposomes, reduced resistance to C. parvum 
infection in mice. Importantly, mice depleted of mac-
rophages were unable to produce IFNγ, indicating that 
macrophages were the alternative source of IFNγ dur-
ing C. parvum infection. In addition, the authors showed 
that IL-18 was an important factor for immunity to C. 
parvum in  Rag2−/− γc−/− mice and IL-18 promoted pro-
duction of IFNγ by macrophages during infection [132]. 
The inability of IFNγ gene-knockout mice to control C. 
parvum infection was associated with reduced recruit-
ment of macrophages and T cells to the lamina propria 
following infection suggesting they play an important 
role in control of infection in mice [133]. The role of 
macrophages in human and ruminant models of crypto-
sporidiosis is currently unknown.
4.2  Adaptive immune response
4.2.1  CD4+ T cells
Cell mediated immunity, particularly CD4+  T cells, is 
essential for the protective immune response to Crypto-
sporidium infection. This is highlighted by the increased 
susceptibility of acquired immune deficiency syndrome 
(AIDS) patients (who have low numbers of CD4+ T cells) 
to C. parvum infection [134], and ability of the parasite to 
cause chronic infections in MHC class II deficient mice 
(which lack functional CD4+ T cells) [135]. Importantly, 
cryptosporidiosis can be resolved in AIDS patients fol-
lowing restoration of their CD4+ T cell levels [135].
4.2.2  Th1 immune responses
A major function of CD4+ T cells is to act as helper lym-
phocytes, and upon interaction with antigen presenting 
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cells, naïve CD4+  T cells can differentiate into various 
helper cell subsets. Differentiation of naïve CD4+ T cells, 
is dictated in part, by the cytokine milieu present at the 
time of differentiation. For example, the presence of 
IL-12 and IFNγ in the local environment results in the 
development of a Th1 immune response which is charac-
terised by the production of TNFα, IL-2 and IFNγ [136]. 
Th1 biased immune responses are important for pro-
tection against intracellular pathogens and are involved 
during Cryptosporidium infection. In bovine studies, 
stimulation of PBMCs from C. parvum-infected calves 
with antigen derived from C. parvum oocysts resulted in 
an increased production of IFNγ by CD4+ T cells [137]. 
PBMCs from neonatal calves experimentally infected 
with C. parvum had increased mRNA levels of the Th1 
cytokines from day 3 post-infection [138]. Similarly, 
expression of IL-12p40 and IFNγ by lamina propria and 
intraepithelial lymphocytes were noted following C. par-
vum infection of neonatal calves [139]. Similarly, a case 
of severe cryptosporidiosis was reported in a patient with 
an IFNγ deficiency [140] and IFNγ gene-knockout mice 
are highly susceptible to infection [141]. Treatment of 
immunocompetent or immunodeficient mice with exog-
enous IL-12 prior to infection with C. parvum reduced 
the severity of infection in an IFNγ dependent manner 
[142]. However, in a study comparing  Rag2−/− and wild 
type neonatal mice, it was demonstrated that CD4+  T 
cells were not required for control of C. parvum infection 
[143].
Taken together, these studies highlight the importance 
of Th1 polarised CD4+ T cell responses during C. par-
vum infection of cattle, humans and mice.
4.2.3  Th2 immune responses
Th2 polarisation of the immune response is driven by the 
presence of an IL-4 rich cytokine milieu which induces 
the differentiation of naïve CD4+  T cells into the Th2 
subset of CD4+  T cells, characterised by their produc-
tion of IL-4, IL-5, IL-10 and IL-13. Th2 responses are 
important in defence against extracellular pathogens, 
allergy/asthma and antibody mediated immunity [144].
Treatment of C57BL/6 mice with anti-IL-4 monoclo-
nal antibody prior to infection with C. parvum caused 
prolonged excretion of C. parvum oocysts for at least 
11  days longer than control mice. Furthermore, IL-4 
deficient mice also exhibited prolonged excretion of C. 
parvum oocysts, which lasted 23 days longer than mice 
with intact IL-4 [145]. Interestingly, in a study using IL-4 
deficient mice, IL-4Rα deficient mice and IL-4 neutral-
ising antibody, it was demonstrated that production of 
IL-4 during C. parvum infection of BALB/c mice induced 
expression of IFNγ and IL-12 and therefore promoted 
Th1 immunity in the intestine [146]. Thus, production of 
the Th2 cytokine IL-4 in response to murine C. parvum 
infection may drive protective Th1 immune responses.
4.2.4  Th17 immune responses
A third subset of CD4+  T cells, distinct from Th1 and 
Th2 CD4+  T cells, was described in 2005 and named 
the Th17 subset of CD4+ T cells [147]. The presence of 
TGFβ, IL-6 and IL-23 in the local environment results in 
differentiation of Th17 cells which are characterised by 
the production of IL-17 (also known as IL-17A). Th17 
CD4+  T cells are important in host defence against a 
wide range of pathogens, for example, through recruit-
ment of macrophages and neutrophils to the site of 
infection [148]. In mice immunosuppressed by dexa-
methasone and then infected with C. parvum, it was 
shown that mRNA levels of TGF-β and IL-6 in the gut 
associated lymphoid tissue (GALT) increased at 6 and 
12  h post-infection respectively. This was alongside 
increased levels of STAT-3 and the transcription factor 
RORγT, which promote differentiation of naïve CD4+ T 
cells into Th17 cells. Consequently, levels of IL-17 pro-
tein increased in the GALT after infection [149]. There 
is little known about the possible role of Th17 immune 
response during the bovine immune response to C. par-
vum infection.
4.2.5  CD8+ T cells
CD8+ T cells, alongside CD4+ T cells and γδ T cells, are 
present at an increased frequency within the ileum of C. 
parvum-infected calves at day 3 post-infection, compared 
with tissues from uninfected calves [118]. Furthermore, 
following infection of 1  day old lambs with C. parvum, 
CD8+/NKp46− lymphocytes (which the authors con-
cluded were most likely to be CD8+ T cells) were signifi-
cantly increased in the small intestine at day 3 and day 
6 post infection, reflecting their recruitment following 
infection [114]. Therefore, CD8+  T cells appear to be 
involved in the immune response after infection of calves 
and lambs with C. parvum. Conversely, in studies using 
MHC class I deficient mice, which lack CD8+ T cells, it 
was shown that mice were not susceptible to C. parvum 
infection whereas mice which lacked CD4+ T cells due 
to a MHC class II deficiency were highly susceptible to 
infection. Thus it appears that CD4+ T cells, rather than 
CD8+  T cells, are important during murine C. parvum 
infection [150].
4.2.6  B cells
The relevance of B cells and immunoglobulins during 
Cryptosporidium infection remains controversial. Mice 
depleted of B cells (and therefore unable to produce 
appropriate levels of protective antibody) were able to 
control C. parvum infection to a similar level as mice 
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with intact B cells [151]. Using gene-targeted B cell defi-
cient mice, it has also been shown that B cells were not 
required for resistance to initial C. parvum infection 
or resolution of infection [152]. Data from these stud-
ies suggest that B cells and antibody-mediated immune 
responses may not be necessary for protection against 
murine C. parvum infection. Whether the same is true 
for protection against Cryptosporidium infection in natu-
ral host species remains to be determined.
4.2.7  Models to study the interaction 
between Cryptosporidium and the host
Generally, mice infected with C. parvum have limitations 
when used as models for Cryptosporidium infection in 
humans or cattle. Additionally, bovine-specific examples 
such as the significantly increased frequency of noncon-
ventional T cells, ultralong complementarity-determin-
ing region 3 (CDR3) domain antibodies and uniquely 
expanded NK receptor repertoires [153–155] illustrate the 
many fundamental differences between the murine and 
bovine immune systems. The impact that these factors may 
play during Cryptosporidium infection cannot be captured 
using mouse models. Improved in  vitro models would 
also ideally be developed in order to enable the study of 
the interaction between C. parvum and the host. To date, 
epithelial cell lines (particularly the HCT-8 cell line) have 
been utilised to decipher the interaction between the par-
asite and human intestinal epithelial cells. Whilst these 
studies are valuable, epithelial cell lines are not fully repre-
sentative of the complex structure and cellular diversity of 
the intestinal epithelium, which consists of many cell types 
including epithelial cells, goblet cells, stem cells, Paneth 
cells and enteroendocrine cells. Intestinal organoids, or 
‘mini guts’, appear to represent an example of a physiolog-
ically-relevant in vitro system that has the potential to fill 
this important requirement gap. These are three dimen-
sional structures, differentiated in  vitro from intestinal 
stem cells, which recapitulate the structure of the intestinal 
epithelium in vivo and contain all of the cell types associ-
ated with the intestine. Organoids would be excellent tools 
to study the early interactions of Cryptosporidium with the 
gut epithelium, as pathogens can be introduced into the 
lumen of the intestinal organoids in  vitro enabling their 
relationship with the host to be deciphered in a physiologi-
cally relevant context. Zhang et al. provided the first study 
of C. parvum and intestinal organoids, which were derived 
from mouse tissue. The authors illustrated that the pres-
ence of C. parvum attenuated the differentiation of murine 
intestinal organoids [156]. Therefore, similar in vitro sys-
tems would be advantageous to understand the nature of 
the host–pathogen interaction during C. parvum infection 
in cattle, and other relevant host species.
5  Concluding remarks
Despite being discovered over 100  years ago Crypto-
sporidium remains one of the most difficult pathogens 
to control on farms and in the environment. To date, 
progress in the development of effective treatments 
for humans or animals has been slow. This may be due, 
in part, to the lack of understanding of the cellular and 
molecular interactions that occur in the gut mucosa dur-
ing the early stage interactions between host and para-
site. The majority of studies that have been carried out 
have focussed on mice, an asymptomatic model. There-
fore, a more in-depth understanding of the pathogenesis 
of Cryptosporidium infection in clinically relevant hosts 
is urgently required. Data derived from these studies is 
necessary to help identify the factors that influence dis-
ease resistance and recovery, and to aid the development 
of effective control strategies to help control this impor-
tant disease.
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